In vivo, the suboptimal human therapeutic equivalent doses of drugs in combination, showed more tumor reduction than the drugs used individually and this is associated with the downregulation of critical signal transduction molecules including pMAPK, pSTAT3 and PCNA along with better tumor differentiation. The gene discussed is PCNA; the disease is neoplasm.